■ Autoimmune thyroiditis and myasthenia gravis
Angela Lopomo, Sonia Berrih-Aknin
Front Endocrinol (Lausanne) 2017; vol 8: 169
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5508005/
■ Thymectomy for myasthenia gravis: What´s next?
M de Perrot, L Donahoe
J Thorac Dis 2017, vol 9 (2): 237-239
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5334076/
■ Thymectomy in myasthenia gravis
Yener Aydin, Ali Bilal Ulas, Vahit Mutlu, Abdurrahim Colak, Atilla Eroglu
Eurasian J Med. 2017 ,vol 49(1): 48–52
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5389494/
■ Randomized Trial of thymectomy in myasthenia gravis
G.I. Wolfe, H.J. Kaminski, I.B. Aban et al
N Engl J Med. 2016 Aug 11; 375(6): 511–522
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5189669/
■ Rare association of celiac disease with myasthenia gravis in a patient with other immune disorders: a Case Report.
Almeida-Menezes, Marcela de et al.
Rev. esp. enferm. dig., Sept 2016, vol.108, no.9, p.586-588
http://scielo.isciii.es/scielo.php?script=sci_arttext&pid=S1130-01082016000900015&lng=en&nrm=iso
■ Acute exacerbation of myasthenia gravis with topicalimiquimod use
Saadeddine Saad, Bobbak Mansouri, Chad Housewright
Proc (Bayl Univ Med Cent) 2017 Jul; 30(3): 333.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5468034/
■ Single-fiber electromyography in the orbiculareis oculi muscle in patient with ocular myasthenia gravis symptoms: does abnormal jitter predict response to treatment?
Goran Rakocevic, Mark Moster, Mary Kay Floeter
BMC Neurol. 2017; 17: 108
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5463377/
■ Tracheoesophageal fistula caused by tracheostomy in a patient with myasthenia gravis after a myasthenia crisis
Chen Jiaxin, Li Jingjing, Zhu Kai, Zhou Zhou, Liu Weibin, Wang Haiyan, Feng Huiyu
Front Neurol. 2017; 8: 217.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5437160/
■ Quantitative Myasthenia Gravis Score: a Brazilian multicenter study for translation, cultural adaptation and validation
Oliveira, Ezequiel Fernandes et al.
Arq. Neuro-Psiquiatr., July 2017, vol.75, no.7, p.457-463
■ Brazilian-Portuguese translation, cross-cultural adaptation and validation of the Myasthenia Gravis Composite scale. A multicentric study
Oliveira, Ezequiel Fernandes et al.
Arq. Neuro-Psiquiatr., Nov 2016, vol.74, no.11, p.914-920
http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0004-282X2016001100914&lng=en&nrm=iso
■ Implicações anestésicas na miastenia gravis – revisão da literatura
M F Medeiros, M V Nunes, L G T dos Santos, R B Ravaiane
Revista Médica de Minas Gerais 2016, vol 26 (suppl 1)
http://www.rmmg.org/artigo/detalhes/1937
■ Labour market participation and sick leave among patients diagnosed with myasthenia gravis in Denmark 1927-2011: a Danish nationwide cohort study
Asger Frost, Marie Louise Svendsen, Jes Rahbek et al
BMC Neurol. 2016; 16: 224
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5114816/
■ Anti´-musk positive myasthenia gravis and three semiological cardinal signs
André P.C. Matta, Ana C. Andorinho F. Ferreira, Arielle Kirmse et al
Neurol Int. 2016 Nov 2; 8(4): 636
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5226044/
■ Regulatory B cells in seropositive myasthenia gravis versus healthy controls
Md Rezaul Karim, Hong-Yan Zhang, Jiang Yuan, Qiang Sun, Yun-Fu Wang
Front Neurol. 2017; 8: 43
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5317198/
■ Non-neuronal cholinergic activity is potentiated in myasthenia gravis
Bin Han, Chao Zhang, Shoufeng Liu, Yiping Xia, et al
BMC Neurol. 2017; 17: 28
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5299729/
■ Clinical predictors for the prognosis of myasthenia gravis
Lili Wang, Yun Zhang, Maolin He
BMC Neurol. 2017; 17: 77.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5395963/
■ Myasthenia gravis: a clinical-immunological update
S Binks, A Vincent, J Palace
Journal of Neurology 2016, vol 263 (4): 826-834
https://link.springer.com/article/10.1007/s00415-015-7963-5
■ Current treatment, emerging translational therapies, and new therapeutics target for autoimmune myasthenia gravis
Jeffrey T. Guptill, Madhu Soni, Matthew N. Meriggioli
Neurotherapeutics. 2016 Jan; 13(1): 118–13
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4720661/
■ New diagnosis myasthenia gravis and preeclampsia in late pregnancy
John Ozcan, Ian Frank Balson, Alicia T Dennis
BMJ Case Rep. 2015; 2015: bcr2014208323
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4342656/
■ Complicating autoimmune diseases in myasthenia gravis: a review
A Nacu, J B Andersen, V Lisnic et al
Autoimmunity 2015, vol 48 (6): 362-368
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4616023/
■ Guidelines for the treatment of ocular myasthenia
EFNS/ENS
E Kerty, A Elsais, Z Argoy et al
European Journal of Neurology 2014, vol 21 (5): 687-693
http://onlinelibrary.wiley.com/doi/10.1111/ene.12359/full
■ Myasthenia gravis: an update for the clinician
J P Sieb
Clin Exp Immunol 2014, vol 175 (3): 408-418
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3927901/
■ Total drug treatment and comorbidity in myasthenia gravis: a population-based cohort study
J B Andersen, J F Owe, A Engeland et al
European Journal of Neurology 2014, vol 21 (7): 948-955
http://onlinelibrary.wiley.com/doi/10.1111/ene.12439/full
■ Severe preeclampsia in the setting of myasthenia gravis
Adam J. Lake, Antoun Al Khabbaz, Renée Keeney
Case Rep Obstet Gynecol. 2017; 2017: 9204930
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5322431/
■ Pyridostigmine induced prolonged asystole in a patient with myasthenia gravis successfully treated with hyoscyamine
M S Khan, A Tiwari, Z Khan et al
Case Reports in Cardiology 2017 (2017), Article ID 6956298, 4 pages
https://www.hindawi.com/journals/cric/2017/6956298/
■ by Dr Paulo Fernando Leite
Cardiologia – Centro Médico Unimed BH
Rua Gonçalves Dias 202
Belo Horizonte/MG/Brasil
31 30033306 / 40204020
CRMMG: 7026
Email: pfleite1873@gmail.com